<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJNeph</journal-id><journal-title-group><journal-title>Open Journal of Nephrology</journal-title></journal-title-group><issn pub-type="epub">2164-2842</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojneph.2018.81002</article-id><article-id pub-id-type="publisher-id">OJNeph-82852</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Prognosis of Acute Renal Failure of the Child during Severe Malaria in Niamey-Niger
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zeinabou</surname><given-names>Maïga Moussa Tondi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Moumouni</surname><given-names>Garba</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Guillaume</surname><given-names>Mahamat Abderraman</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hassane</surname><given-names>Diongole Moussa</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ibrahim</surname><given-names>Hamat</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Elmoctar</surname><given-names>Seydou Toure</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ide</surname><given-names>Abdou</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Illiassou</surname><given-names>Soumeila Toure</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aboubacar</surname><given-names>Illiassou</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Salamatou</surname><given-names>Niourou</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Service de Néphrologie Hémodialyse, H&amp;amp;ocirc;pital de la Renaissance de N’Djamena, N’Djamena, Tchad</addr-line></aff><aff id="aff1"><addr-line>Service de Néphrologie Hémodialyse, Faculté des sciences de la santé Université Abdou Moumouni Niger, Niamey, Niger</addr-line></aff><aff id="aff4"><addr-line>Service de Néphrologie, H&amp;amp;ocirc;pital National de Zinder, Zinder, Niger</addr-line></aff><aff id="aff2"><addr-line>Service de Pédiatrie, H&amp;amp;ocirc;pital National de Niamey, Niamey, Niger</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>zeinab_maiga@yahoo.fr(ZMMT)</email>;<email>zalba2001@yahoo.fr(GMA)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>03</month><year>2018</year></pub-date><volume>08</volume><issue>01</issue><fpage>10</fpage><lpage>17</lpage><history><date date-type="received"><day>28,</day>	<month>November</month>	<year>2017</year></date><date date-type="rev-recd"><day>5,</day>	<month>March</month>	<year>2018</year>	</date><date date-type="accepted"><day>8,</day>	<month>March</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: In malaria-endemic areas, acute renal failure (ARF) is one of the most serious complications, it occurs in 40% of severe forms of malaria in adults and is linked to 75% of deaths, especially when extra-renal cleaning is not available. In children, studies of ARF during malaria are limited. We have no published studies on this topic in Niger. The main objective of our study is to evaluate the prognosis of ARF during severe malaria in children. 
  Patients and Method
  : This is a one-year prospective study (January 1, 2016 to December 31, 2016) conducted in the resuscitation unit of the pediatric department of the National Lamord&#233; Hospital of Niamey (Niger). We included in the study children aged 0 to 15 years hospitalized for severe malaria with impaired renal function. Patients who had chronic renal failure or who had acute renal failure with a thick negative drop were excluded from the study. Acute renal failure is defined according to Kidney Disease Improving Global Outcomes (KDIGO) criteria basing on creatinine clearance. 
  Results: The incidence of ARF was 12.60%. The mean age of the patients was 4.25 &#177; 1.3 years [8 months - 15 years]. The mean hemoglobin level was 8.2 &#177; 2.7 g/dl. In 54.02% of cases, the hemoglobin level is ≤5 g/dl. Mean serum creatinine was 543.7 &#177; 69.5 μmol/l [107 - 2500 μmol/l] and mean azotemia was 27.5 &#177; 3.5 mmol/l. Severe anemia (54.02%) were more related to the occurrence of ARF(with p = 0.014). According to the RIFLE classification, 55 patients (63.22%) were in the Risk stage, 18 patients (20.69%) were in the injury stage and 14 patients (16.09%) in the failure stage. All patients were placed on injectable Artesunate. The average length of hospital stay was 8.6 &#177; 4.5 days [5 to 22 days]. Dialysis was reported in 15/87 (17.24%). For technical and financial reasons only 8 patients were hemodialysed. Indications for dialysis were severe uremic syndrome 7 cases (8.04%), fluid overload 5 cases (5.75%) and severe hyperkalemia 3 cases (3.45%). 
  Conclusion: The etiological factors of ARI in malaria were massive hemoglobinuria, severe anemia and shock. Adequate management of simple cases of malaria and the early transfer of severe cases to resuscitation services can prevent certain complications such as acute renal failure.
 
</p></abstract><kwd-group><kwd>Acute Renal Injury</kwd><kwd> Malaria</kwd><kwd> Niger</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Malaria is the most common parasitic disease in the world. It represents a major public health problem, especially in tropical and subtropical countries [<xref ref-type="bibr" rid="scirp.82852-ref1">1</xref>] . About 500 million people worldwide have malaria each year. It is responsible for 1 to 3 million deaths a year [<xref ref-type="bibr" rid="scirp.82852-ref1">1</xref>] . Children and women pay the highest price for the disease. More than two-thirds (70%) of deaths from malaria occur in the under-5 age group. Severe forms are the most lethal of the disease [<xref ref-type="bibr" rid="scirp.82852-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.82852-ref2">2</xref>] . Acute renal failure is one of the most serious complications. In malaria-endemic areas, acute renal failure (ARF) occurs in 40% of severe forms of malaria in adults and is linked to 75% of deaths, especially when extra-renal cleansing is not available [<xref ref-type="bibr" rid="scirp.82852-ref3">3</xref>] . In children, studies of ARF during malaria are limited. In an Indian study [<xref ref-type="bibr" rid="scirp.82852-ref4">4</xref>] , the incidence of ARF during malaria ranged from 13% to 17.8%. In a Congolese series [<xref ref-type="bibr" rid="scirp.82852-ref5">5</xref>] , the incidence of ARI in severe forms of malaria was 23.06% with an intra-hospital mortality of 12.6%. In Niger, according to the estimates of the national malaria control program, 770,000 cases were recorded in 2015. It is responsible for 50% of deaths in children under 5 years of age [<xref ref-type="bibr" rid="scirp.82852-ref6">6</xref>] . We have no published studies on ARI and severe childhood malaria in Niger. The main objective of our study is to evaluate the prognosis of ARI during severe malaria in children.</p></sec><sec id="s2"><title>2. Patients and methods</title><p>This is a one-year prospective study (January 1, 2016 to December 31, 2016) conducted in the resuscitation unit of the pediatric department of the National Lamord&#233; Hospital (NLH) in Niamey. The unit has about twenty beds. It serves to stabilize patients in life-threatening situations prior to hospitalization in the pediatric ward. The NLH serves the populations of the right bank of the capital Niamey. It is a region where malaria transmission is endemic with a peak of infestation during wintering (July, August and September). We included in the study children aged 0 to 15 years hospitalized for severe malaria with impaired renal function. Patients who had chronic renal failure or who had acute renal failure with a thick negative drop were excluded from the study. Acute renal failure is defined according to criteria of Kidney Disease Improving Global Outcomes (KDIGO) basing on clearance of creatinine [<xref ref-type="bibr" rid="scirp.82852-ref7">7</xref>] . The glomerular filtration rate was estimated by the Schwartz formula: Creatinine clearance (ml/min per 1.73 m<sup>2</sup>) = [Size (cm) &#215; k]/Cr (mg/dl), k = 0.413 (constant for children aged 1 to 13). Renal impairment is defined as a serum creatinine elevation ≥ 0.3 mg/dl (26 μmol/l) within 48 hours or an increase in serum creatinine ≥ 1.5 times the normal reference value. ARI stage 1 corresponds to serum creatinine ≥26 μmol/l within 48 hours or serum creatine elevation 1.5 to 1.9 times normal; stage 2 = creatine ≥ 2 to 2.9 times normal; stage 3 = creatine ≥ 3 times normal or creatine serum ≥ 4 mg/dl (354 μmol/l). Severe forms of malaria have been defined according to the WHO Malaria Severity Criteria 2012 [<xref ref-type="bibr" rid="scirp.82852-ref1">1</xref>] . The severe forms of malaria are: severe neurological form (severe malaria neurological form) which is defined by at least one seizure within 24 hours, impaired consciousness or coma with a score of Blantyre ≤ 2 in infants or a Glasgow ≤ 11 in older children with normal lumbar puncture; acute pulmonary edema or acute respiratory distress syndrome; the shock state with cold end; macroscopic hemoglobinuria; hemorrhagic syndrome; jaundice associated with organ dysfunction; hypoglycemia (blood glucose &lt; 2.2 mmol/L or &lt; 40 mg/dl); severe anemic malaria (hemoglobin level &lt; 5 g/dl or hematocrit &lt; 15%); metabolic acidosis (bicarbonate &lt; 8 mmol/l or blood pH &lt; 7.35); hyperparasitaemia (more than 5% or 250,000 parasitized red blood cells/μl); acute renal failure (serum creatinine ≥ 265 μmol/l). The diagnosis of malaria was made by a rapid diagnostic test (RDT) positive and confirmed by a thick drop on capillary positive blood. For each patient, sociodemographic characteristics, clinical signs at admission, paraclinical assessment, management elements and prognosis are collected. The data was processed using the SPSS 20.0 software. Descriptive statistics were used to calculate frequencies, averages and standard deviations. We used the chi<sup>2</sup> test in univariate analyzes. A value p &lt; 0.05 is considered statistically significant.</p></sec><sec id="s3"><title>3. Results</title><p>Six hundred and seventy (690) cases of severe malaria were hospitalized in the intensive care unit during the study period. Of these, 87 had an ARI. The incidence of ARI was 12.60%. The mean age of the patients was 4.25 &#177; 1.3 years with extremes of 8 months to 15 years. More than the majority (54.02) of patients with ARI were male. They were 49/87 (56.32%) older than 5 years old. 72.41% of patients lived in peri-urban areas. The mean duration of progression of the malaria episode before hospitalization was 8.7 &#177; 3.03 days. <xref ref-type="table" rid="table1">Table 1</xref> summarizes the clinical signs at admission. Fever (97.70%), vomiting (81.60%) and oligo-anuria (77.01%) were the most prominent clinical signs. The mean hemoglobin level was 8.2 &#177; 2.7 g/dl. In 54.02% of cases, the hemoglobin level is ≤ 5 g/dl. Mean serum creatinine was 543.7 &#177; 69.5 μmol/l with [107 - 2500 μmol/l] and mean azotemia was 27.5 &#177; 3.5 mmol/l. The probable etiological factors of ARI were summarized in <xref ref-type="table" rid="table2">Table 2</xref>. Massive hemoglobinuria (44.83%) with p = 0.001; oliguria (74.71%) with p = 0.021; severe anemia (54.02%) with p = 0.014 were more</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Clinical signs of patients with ARF at admission</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Signs</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Fever</td><td align="center" valign="middle" >85</td><td align="center" valign="middle" >97.70%</td></tr><tr><td align="center" valign="middle" >Thrill</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >51.72%</td></tr><tr><td align="center" valign="middle" >Headache</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >42.52%</td></tr><tr><td align="center" valign="middle" >Vomiting</td><td align="center" valign="middle" >71</td><td align="center" valign="middle" >81.60%</td></tr><tr><td align="center" valign="middle" >Diarrhea</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >45.98%</td></tr><tr><td align="center" valign="middle" >Convulsions</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >47.12%</td></tr><tr><td align="center" valign="middle" >Abdominal pain</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >14.94%</td></tr><tr><td align="center" valign="middle" >Icterus</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >59.77%</td></tr><tr><td align="center" valign="middle" >Arthralgia</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >49.42%</td></tr><tr><td align="center" valign="middle" >Oligo-anuria</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >77.01%</td></tr><tr><td align="center" valign="middle" >Respiratory distress</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >17.24%</td></tr><tr><td align="center" valign="middle" >Severe dehydration</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >41.37%</td></tr><tr><td align="center" valign="middle" >“Coca-cola” Urine</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >47.12%</td></tr><tr><td align="center" valign="middle" >Disorder of consciousness</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >41.38%</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Characteristics of patients according to acute kidney failure</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Characteristics</th><th align="center" valign="middle" >Without ARF (n = 603)</th><th align="center" valign="middle" >With ARF (n = 87)</th><th align="center" valign="middle" >P-value</th></tr></thead><tr><td align="center" valign="middle"  colspan="4"  >Demographic</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >348 (57.71%)</td><td align="center" valign="middle" >47 (54.02%)</td><td align="center" valign="middle" >0.065</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >342 (42.29%)</td><td align="center" valign="middle" >40 (45.98%)</td><td align="center" valign="middle" >0.085</td></tr><tr><td align="center" valign="middle" >Age ≤ 5 ans</td><td align="center" valign="middle" >404 (67%)</td><td align="center" valign="middle" >38 (43.68%)</td><td align="center" valign="middle" >0.253</td></tr><tr><td align="center" valign="middle" >Age &gt; 5 ans</td><td align="center" valign="middle" >199 (43%)</td><td align="center" valign="middle" >49 (56.32%)</td><td align="center" valign="middle" >0.021</td></tr><tr><td align="center" valign="middle" >Around urbna</td><td align="center" valign="middle" >417 (69.15%)</td><td align="center" valign="middle" >63 (72.41%)</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >Urban</td><td align="center" valign="middle" >186 (30.85%)</td><td align="center" valign="middle" >24 (27.59)</td><td align="center" valign="middle" >0.985</td></tr><tr><td align="center" valign="middle"  colspan="4"  >Clinic</td></tr><tr><td align="center" valign="middle" >Duration of evolution (days)</td><td align="center" valign="middle" >6.7 &#177; 2.5</td><td align="center" valign="middle" >8.7 &#177; 3.03</td><td align="center" valign="middle" >0.003</td></tr><tr><td align="center" valign="middle" >Temperature (˚C)</td><td align="center" valign="middle" >38.1 &#177; 0.79</td><td align="center" valign="middle" >38.3 &#177; 1.01</td><td align="center" valign="middle" >0.740</td></tr><tr><td align="center" valign="middle" >Disorder of consciousness and convulsion</td><td align="center" valign="middle" >193 (32%)</td><td align="center" valign="middle" >40 (45.98%)</td><td align="center" valign="middle" >0.065</td></tr><tr><td align="center" valign="middle" >Respiratory distress</td><td align="center" valign="middle" >86 (14.26%)</td><td align="center" valign="middle" >19 (21.84%)</td><td align="center" valign="middle" >0.875</td></tr><tr><td align="center" valign="middle" >Massive hemoglobinuria</td><td align="center" valign="middle" >54 (8.95%)</td><td align="center" valign="middle" >39 (44.83%)</td><td align="center" valign="middle" >0.0001</td></tr><tr><td align="center" valign="middle" >Hemorrhagic syndrome</td><td align="center" valign="middle" >21 (3.48%)</td><td align="center" valign="middle" >12 (13.79%)</td><td align="center" valign="middle" >0.325</td></tr><tr><td align="center" valign="middle" >Frankish jaundice</td><td align="center" valign="middle" >184 (30.51%)</td><td align="center" valign="middle" >41 (47.12%)</td><td align="center" valign="middle" >0.002</td></tr><tr><td align="center" valign="middle" >State of shock</td><td align="center" valign="middle" >98 (16.25%)</td><td align="center" valign="middle" >23 (26.43%)</td><td align="center" valign="middle" >0.074</td></tr><tr><td align="center" valign="middle" >Oliguria</td><td align="center" valign="middle" >189 (31.34%)</td><td align="center" valign="middle" >65 (74.71%)</td><td align="center" valign="middle" >0.021</td></tr><tr><td align="center" valign="middle" >Severe anemia</td><td align="center" valign="middle" >215 (35.65%)</td><td align="center" valign="middle" >47 (54.02%)</td><td align="center" valign="middle" >0.014</td></tr><tr><td align="center" valign="middle"  colspan="4"  >Paraclinic</td></tr><tr><td align="center" valign="middle" >Hyperparasitemia</td><td align="center" valign="middle" >213 (35.32%)</td><td align="center" valign="middle" >17 (19.54%)</td><td align="center" valign="middle" >0.825</td></tr><tr><td align="center" valign="middle" >White blood cells (10<sup>3</sup>/ml)</td><td align="center" valign="middle" >12.5 &#177; 2.75</td><td align="center" valign="middle" >14.870 &#177; 36</td><td align="center" valign="middle" >0.745</td></tr><tr><td align="center" valign="middle" >Hemoglobin (g/dl)</td><td align="center" valign="middle" >9.9 &#177; 4.5</td><td align="center" valign="middle" >8.2 &#177; 2.7</td><td align="center" valign="middle" >0.321</td></tr><tr><td align="center" valign="middle" >Platelets (10<sup>3</sup>/ml)</td><td align="center" valign="middle" >255 &#177; 25</td><td align="center" valign="middle" >125 &#177; 35</td><td align="center" valign="middle" >0.062</td></tr><tr><td align="center" valign="middle" >Azotemia (mmol/l)</td><td align="center" valign="middle" >5.7 &#177; 3.2</td><td align="center" valign="middle" >27.5 &#177; 3.5</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >Serum Creatinin (&#181;mol/l)</td><td align="center" valign="middle" >11.2 &#177; 5.2</td><td align="center" valign="middle" >543.7 &#177; 69.5</td><td align="center" valign="middle" >0.012</td></tr><tr><td align="center" valign="middle" >Natremia (mmol/l)</td><td align="center" valign="middle" >137 &#177; 25</td><td align="center" valign="middle" >139 &#177; 14</td><td align="center" valign="middle" >0.925</td></tr><tr><td align="center" valign="middle" >Kaliemia (mmol/l)</td><td align="center" valign="middle" >4.7 &#177; 1.5</td><td align="center" valign="middle" >4.9 &#177; 2.8</td><td align="center" valign="middle" >0.065</td></tr></tbody></table></table-wrap><p>related to the occurrence of ARI. According to the RIFLE classification, 55 patients (63.22%) were in the Risk stage, 18 patients (20.69%) were in the injury stage and 14 patients (16.09%) in the failure stage (<xref ref-type="table" rid="table3">Table 3</xref>). All patients were placed on injectable Artesunate combined with adjuvant treatment according to the clinical presentation of the patient. Those with severe anemia were transfused with red blood cells or whole blood. The primary management of ARI was overhydration and/or forced diuresis using intravenous furosemide at a dose of 6 mg/kg/day to be divided into 3 doses. The average length of hospital stay was 8.6 &#177; 4.5 days with extremes of 5 to 22 days. Dialysis was reported in 15/87 (17.24%). For technical and financial reasons, only 8 patients were hemodialysed. Indications for dialysis were severe uremic syndrome in 7 cases (8.04%), fluid overload in 5 cases (5.75%) and severe hyperkalemia in 3 cases (3.45%). Complete recovery of renal function was noted in 63 patients (74%). Partial recovery of renal function was observed in 8 patients (7%) and a change to chronic renal failure in 3 patients. Thirteen patients died during hospitalization. Six on thirteen patients (6/13) of the deceased patients were at stage 3 of acute renal failure. Severe anemia (p = 0.001), massive hemoglobinuria (p = 0.002) and severe malaria neurological form (p = 0.032) were more associated with mortality.</p></sec><sec id="s4"><title>4. Discussion</title><p>Acute renal failure is one of the serious complications of malaria. Our study showed that ARI in severe childhood malaria was more common in males, the majority of patients were older than 5 years. Hemoglobinuria and anemic forms were more associated with the occurrence of ARI. Patient’s mortality in our study, was 14.94%. This mortality is greater during severe malaria neurological form and massive hemoglobinuria and severe malaria neurological form. The incidence of ARI due to malaria in adults in some series was around 6% [<xref ref-type="bibr" rid="scirp.82852-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.82852-ref9">9</xref>] .</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Prognostic factors of severe malaria and ARF</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Factors</th><th align="center" valign="middle" >Survived N = 74</th><th align="center" valign="middle" >Death N =13</th><th align="center" valign="middle" >P-value</th></tr></thead><tr><td align="center" valign="middle" >Hyperparasitaemia</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0.062</td></tr><tr><td align="center" valign="middle" >Severe Anemia</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >Massive hemoglobinuria</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >0.002</td></tr><tr><td align="center" valign="middle" >Hemorrhagic syndrome</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.325</td></tr><tr><td align="center" valign="middle" >Neurological malaria</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0.032</td></tr><tr><td align="center" valign="middle" >Oligo-anuria</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >0.0001</td></tr><tr><td align="center" valign="middle" >State of shock</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.124</td></tr><tr><td align="center" valign="middle" >Frankish jaundice</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0.065</td></tr><tr><td align="center" valign="middle" >Respiratory distress</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.085</td></tr><tr><td align="center" valign="middle"  colspan="4"  >RIFLE Classification</td></tr><tr><td align="center" valign="middle" >RISK</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.985</td></tr><tr><td align="center" valign="middle" >INJURY</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.074</td></tr><tr><td align="center" valign="middle" >FAILURE</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0.05</td></tr></tbody></table></table-wrap><p>Recent studies in children have reported an incidence ranging from 0.6% to 48.6% [<xref ref-type="bibr" rid="scirp.82852-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.82852-ref11">11</xref>] and [<xref ref-type="bibr" rid="scirp.82852-ref12">12</xref>] . During our study, it was 12.60%. The incidence of ARI would be influenced by certain parameters such as sample size, time to admission, degree of malaria infection and admission status of patients [<xref ref-type="bibr" rid="scirp.82852-ref10">10</xref>] . Several factors are involved in the mechanism of occurrence of ARI during malaria. Massive intravascular hemolysis causing hemoglobinuria; cytoadherence and erythrocyte sequestration with intravascular coagulation, responsible for hypo-infusion; dehydration and hypovolemia secondary to fever, profuse sweating, lack of water intake and digestive disorders also leading to renal hypoperfusion; activation of monocytes with release of cytokines, free radicals and immunoglobulins [<xref ref-type="bibr" rid="scirp.82852-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.82852-ref14">14</xref>] . All these phenomena lead to a tubular and cortical necrosis. Among the risk factors for the occurrence of ARI in our study is the massive hemoglobinuria. In a series reported by Kavitha et al. [<xref ref-type="bibr" rid="scirp.82852-ref15">15</xref>] , the important risk factors for the occurrence of ARI during malaria were jaundice, hepatomegaly, low diastolic pressure, hyperbilirubinemia. Several studies of the pediatric population [<xref ref-type="bibr" rid="scirp.82852-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.82852-ref16">16</xref>] and adults reported a higher prevalence (59.78% to 81%) of ARI in males. In our study more than 54% of the patients were male. Some authors support a significant exposure of men to mosquito bites. But in the pediatric population the risk of exposure being the same, additional studies must be conducted to understand the phenomenon. The oligoanuric form of ARI (77%) is the most important in our study. Several pediatric studies [<xref ref-type="bibr" rid="scirp.82852-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.82852-ref17">17</xref>] reported similar results. It is more related to hypovolemia due to vomiting and diarrhea that are common in children. Dialysis was indicated in 15 patients but only 8 had benefit from it. The absence of peritoneal dialysis, the very high cost of the procedure and the altered state of some patients were the limiting factors in its implementation. Other African studies [<xref ref-type="bibr" rid="scirp.82852-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.82852-ref19">19</xref>] have reported similar findings. Despite the limitation of our means of care, 74% of the survivors had completely recovered their renal function and 7% partially. Kapil et al. [<xref ref-type="bibr" rid="scirp.82852-ref10">10</xref>] in India reported similar results. In our study, the mortality was 14.94%. It was similar to that reported in the sub region. Other series have reported much higher mortality ranging from 33.3% to 46.2% [<xref ref-type="bibr" rid="scirp.82852-ref20">20</xref>] . The risk factors for mortality in our study were severe anemia, neurological form, and massive hemoglobinuria. For Kapil et al. [<xref ref-type="bibr" rid="scirp.82852-ref10">10</xref>] , the risk factors for death were oliguria, shock, disseminated intravascular coagulation, central nervous system involvement and respiratory distress syndrome. The occurrence of all these signs summarizes a multi-visceral dysfunction [<xref ref-type="bibr" rid="scirp.82852-ref21">21</xref>] . The limitations of our study are the relatively small size of our sample, the lack of daily monitoring of certain parameters such as diuresis, creatinine and the absence of certain technical means such as peritoneal dialysis. Despite this, we believe that it has brought the light to better understand the incidence, etiological factors and prognosis of ARI during childhood malaria.</p></sec><sec id="s5"><title>5. Conclusion</title><p>In our study, the incidence of ARI during malaria was 12.60%. For the male gender, children over the age of 5 were more exposed to the ARI. The etiological factors were massive hemoglobinuria, severe anemia and shock. Patient’s mortality in our study was 14.94%. The risk factors for death were hemoglobinuria, severe malaria, anemic and neurological form. Adequate management of simple cases of malaria and the early transfer of severe cases to resuscitation services can prevent certain complications such as acute renal failure.</p></sec><sec id="s6"><title>Interest conflict</title><p>The authors do not declare any conflict of interest.</p></sec><sec id="s7"><title>Ethics Committee</title><p>The preliminary agreement has been obtained.</p></sec><sec id="s8"><title>Cite this paper</title><p>Tondi, Z.M.M., Garba, M., Abderraman, G.M., Moussa, H.D., Hamat, I., Toure, E.S., Abdou, I., Toure, I.S., Illiassou, A. and Niourou, S. (2018) Prognosis of Acute Renal Failure of the Child during Severe Malaria in Niamey-Niger. Open Journal of Nephrology, 8, 10-17. https://doi.org/10.4236/ojneph.2018.81002</p></sec><sec id="s9"><title>Abbreviations</title><p>ARF acute renal failure;</p><p>ARI: acute renal injury;</p><p>NLH: National Lamord&#233; Hospital;</p><p>RIFLE: “risk”, “injury”, “failure”, “lost” and “end stage”.</p></sec></body><back><ref-list><title>References</title><ref id="scirp.82852-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2012) Management of Severe Malaria: A Practical Handbook. World Health Organization Press, Italy, 89 p.</mixed-citation></ref><ref id="scirp.82852-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Murray, C.L., Rosenfield, L.C., Stephen, L.S., et al. (2012) Global Malaria Mortality between 1980 and 2010: A Systematic Analysis. The Lancet, 379, 413-431.  
&lt;br /&gt;https://doi.org/10.1016/S0140-6736(12)60034-8</mixed-citation></ref><ref id="scirp.82852-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Dondorp, A., Nosten, F., Stepniewska, K., et al. (2005) Artesunate versus Quinine for Treatment of Severe Falciparum Malaria: A Randomised Trial. The Lancet, 366, 717-725. &lt;br /&gt;https://doi.org/10.1016/S0140-6736(05)67176-0</mixed-citation></ref><ref id="scirp.82852-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Mehta, K.S., Halankar, A.R., Makwana, P.D., Torane, P.P., Satija, P.S. and Shah, V.B. (2001) Severe Acute Renal Failure in Malaria. Journal of Postgraduate Medicine, 47, 24-26.</mixed-citation></ref><ref id="scirp.82852-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Kunuanunua, T.S., Nsibu, C.N., Gini-Ehungu, J.L., Bodi, J.M., Ekulu, P.M., Situakibanza, H., Nseka, N.M., Magoga, K. and Aloni, M.N. (2013) Insuffisance rénale aigue dans les formes graves du paludisme chez les enfants vivant à Kinshasa. Néphrologie &amp; Thérapeutique, 9, 160-165.  
&lt;br /&gt;https://doi.org/10.1016/j.nephro.2013.01.001</mixed-citation></ref><ref id="scirp.82852-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Institut National de la Statistique (INS) et ICF International (2013) Enquête Démographique et de Santé et à Indicateurs Multiples du Niger 2012. INS et ICF International, Calverton, Maryland.</mixed-citation></ref><ref id="scirp.82852-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Kellum, J.A. and Lameire, N. (2013) Diagnosis, Evaluation, and Management of Acute Kidney Injury: A KDIGO Summary (Part 1). Critical Care, 17, 204.  
&lt;br /&gt;https://doi.org/10.1186/cc11454</mixed-citation></ref><ref id="scirp.82852-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Naqvi, R., Ahmad, E., Akhtar, F., Naqvi, A. and Rizvi, A. (2003) Outcome in Severe Acute Renal Failure Associated with Malaria. Nephrology Dialysis Transplantation, 18, 1820-1823. &lt;br /&gt;https://doi.org/10.1093/ndt/gfg260</mixed-citation></ref><ref id="scirp.82852-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Prakash, J., Gupta, A., Kumar, O., et al. (1996) Acute Renal Failure in Falciparum Malaria: Increasing Prevalence in Some Areas of India. Nephrology Dialysis Transplantation, 11, 2414-2416. &lt;br /&gt;https://doi.org/10.1093/oxfordjournals.ndt.a027206</mixed-citation></ref><ref id="scirp.82852-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Kapoor, K. and Gupta, S. (2012) Malarial Acute Kidney Injury in a Paediatric Intensive Care Unit. Tropical Doctor, 42, 203-205.  
&lt;br /&gt;https://doi.org/10.1258/td.2012.120196</mixed-citation></ref><ref id="scirp.82852-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Jallow, M., Casals-Pascual, C., Ackerman, H., et al. (2012) Clinical Features of Severe Malaria Associated with Death: A 13-Year Observational Study in Gambia. PLoS ONE, 7, e45645. &lt;br /&gt;https://doi.org/10.1371/journal.pone.0045645</mixed-citation></ref><ref id="scirp.82852-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Esezobor, C.I., Ladapo, T.A., Osinaike, B. and Afolabi Lesi, F.E. (2012) Paediatric Acute Kidney Injury in a Tertiary Hospital in Nigeria: Prevalence, Causes and Mortality Rate. PLoS ONE, 7, e51229. &lt;br /&gt;https://doi.org/10.1371/journal.pone.0051229</mixed-citation></ref><ref id="scirp.82852-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Conroy, A.L., Hawkes, M., Elphinstone, R.E., et al. (2016) Acute Kidney Injury Is Common in Pediatric Severe Malaria and Is Associated with Increased Mortality. Open Forum Infectious Diseases, 3, No. 2. &lt;br /&gt;https://doi.org/10.1093/ofid/ofw046</mixed-citation></ref><ref id="scirp.82852-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Nandwani, S., Pande, A. and Saluja, M. (2014) Clinical Profile of Severe Malaria: Study from a Tertiary Care Center in North India. Journal of Parasitic Diseases, 38, 11-15. &lt;br /&gt;https://doi.org/10.1007/s12639-012-0208-y</mixed-citation></ref><ref id="scirp.82852-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Saravu, K., Rishikesh, K. and Parikh, C.R. (2014) Risk Factors and Outcomes Stratified by Severity of Acute Kidney Injury in Malaria. PLoS ONE, 9, e90419.</mixed-citation></ref><ref id="scirp.82852-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Zaki, S.A., Shenoy, P., Shanbag, P., Mauskar, A., Patil, A. and Nagotkar, L. (2013) Acute Renal Failure Associated with Malaria in Children. Saudi Journal of Kidney Diseases and Transplantation, 24, 303-308.  
&lt;br /&gt;https://doi.org/10.4103/1319-2442.109585</mixed-citation></ref><ref id="scirp.82852-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Olowu, W.A. and Adelusola, K.A. (2004) Pediatric Acute Renal Failure in Southwestern Nigeria. Kidney International, 66, 1541-1548.  
&lt;br /&gt;https://doi.org/10.1111/j.1523-1755.2004.00918.x</mixed-citation></ref><ref id="scirp.82852-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Aloni, N.M., Nsangu, M., Kunuanunua, T., Kadima, T.B. and Muanda, T.F. (2010) Haemolytic Crisis of Blackwater Fever Following Artemether-Lumefantrine Intake. Bulletin de la Société de Pathologie Exotique, 103, 296-298.  
&lt;br /&gt;https://doi.org/10.1007/s13149-010-0076-6</mixed-citation></ref><ref id="scirp.82852-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Assounga, A.G., Assambo-Kieli, C., Mafoua, A., Moyen, G. and Nzingoula, S. (2000) Etiology and Outcome of Acute Renal Failure in Children in Congo-Brazzaville. Saudi Journal of Kidney Diseases and Transplantation, 11, 40-43.</mixed-citation></ref><ref id="scirp.82852-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Sheiban, A.K. (1999) Prognosis of Malaria Associated Severe Acute Renal Failure in Children. Renal Failure, 21, 63-66. &lt;br /&gt;https://doi.org/10.3109/08860229909066970</mixed-citation></ref><ref id="scirp.82852-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Thanachartwet, V., Desakorn, V., Sahassananda, D., Win, K.K. and Supaporn, T. (2013) Acute Renal Failure in Patients with Severe Falciparum Malaria: Using the WHO 2006 and RIFLE Criteria. International Journal of Nephrology, 2013, Article ID: 841518. &lt;br /&gt;https://doi.org/10.1155/2013/841518</mixed-citation></ref></ref-list></back></article>